Literature DB >> 28962214

Mislocalization of Runt-related transcription factor 3 results in airway inflammation and airway hyper-responsiveness in a murine asthma model.

Xiaoyan Zhou1, Jinxiao Zhu2, Tao Bian3, Ruiqian Wang3, Fei Gao3.   

Abstract

The Runt-related transcription factor (RUNX) gene family consists of three members, RUNX1, -2 and -3, which heterodimerize with a common protein, core-binding factor β, and contain the highly conserved Runt-homology domain. RUNX1 and -2 have essential roles in hematopoiesis and osteogenesis. Runx3 protein regulates cell lineage decisions in neurogenesis and thymopoiesis. The aim of the present study was to determine the expression features of the Runx3 protein in a murine asthma model. In vivo, Runx3 protein and mRNA were found to be almost equivalently expressed in the murine lung tissue of the control, ovalbumin (OVA) and genistein groups; however, the nuclear Runx3 protein was abated in lung tissue in OVA-immunized and challenged mice. Following treatment with genistein, which is a flavonoid previously demonstrated to decrease airway inflammation in asthma, the allergic airway inflammation and airway hyper-responsiveness were attenuated and the Runx3 protein tended to augment in the nucleus. These results were further determined in vitro. These results indicated that the mislocalization of Runx3 protein is a molecular mechanism of allergic inflammation and airway hyper-responsiveness in a murine asthma model.

Entities:  

Keywords:  airway inflammation; asthma; genistein; interleukin-2-inducible T cell kinase inhibitor; runx3

Year:  2017        PMID: 28962214      PMCID: PMC5609286          DOI: 10.3892/etm.2017.4812

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  44 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Genistein attenuated allergic airway inflammation by modulating the transcription factors T-bet, GATA-3 and STAT-6 in a murine model of asthma.

Authors:  Fei Gao; Dong Wei; Tao Bian; Ping Xie; Jian Zou; Huijun Mu; Bin Zhang; Xiaoyan Zhou
Journal:  Pharmacology       Date:  2012-04-13       Impact factor: 2.547

3.  Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.

Authors:  S Wang; Q Wang; B E Crute; I N Melnikova; S R Keller; N A Speck
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

4.  Attenuation of immunological symptoms of allergic asthma in mice lacking the tyrosine kinase ITK.

Authors:  Cynthia Mueller; Avery August
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

5.  Selective Itk inhibitors block T-cell activation and murine lung inflammation.

Authors:  Tai-An Lin; Kim W McIntyre; Jagabandhu Das; Chunjian Liu; Kathleen D O'Day; Becky Penhallow; Chen-Yi Hung; Gena S Whitney; David J Shuster; XiaoXia Yang; Robert Townsend; Jennifer Postelnek; Steven H Spergel; James Lin; Robert V Moquin; Joseph A Furch; Amrita V Kamath; Hongjian Zhang; Punit H Marathe; Juan J Perez-Villar; Arthur Doweyko; Loran Killar; John H Dodd; Joel C Barrish; John Wityak; Steven B Kanner
Journal:  Biochemistry       Date:  2004-08-31       Impact factor: 3.162

6.  Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells.

Authors:  Jun Xia; Long Cheng; Chuanzhong Mei; Jia Ma; Ying Shi; Fanpeng Zeng; Zhenghuan Wang; Zhiwei Wang
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  5-Aminomethylbenzimidazoles as potent ITK antagonists.

Authors:  Doris Riether; Renée Zindell; Jennifer A Kowalski; Brian N Cook; Jörg Bentzien; Stéphane De Lombaert; David Thomson; Stanley Z Kugler; Donna Skow; Leslie S Martin; Ernest L Raymond; Hnin Hnin Khine; Kathy O'Shea; Joseph R Woska; Deborah Jeanfavre; Rosemarie Sellati; Kerry L M Ralph; Jennifer Ahlberg; Gabriel Labissiere; Mohammed A Kashem; Steven S Pullen; Hidenori Takahashi
Journal:  Bioorg Med Chem Lett       Date:  2009-02-08       Impact factor: 2.823

8.  Runx3 inhibits IL-4 production in T cells via physical interaction with NFAT.

Authors:  Sung Ho Lee; Hyung Min Jeong; Jin Myung Choi; Young-Chang Cho; Tae Sung Kim; Kwang Youl Lee; Bok Yun Kang
Journal:  Biochem Biophys Res Commun       Date:  2009-02-12       Impact factor: 3.575

Review 9.  RUNX proteins in transcription factor networks that regulate T-cell lineage choice.

Authors:  Amélie Collins; Dan R Littman; Ichiro Taniuchi
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

10.  Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.

Authors:  Yuanyuan Li; Syed M Meeran; Shweta N Patel; Huaping Chen; Tabitha M Hardy; Trygve O Tollefsbol
Journal:  Mol Cancer       Date:  2013-02-04       Impact factor: 27.401

View more
  4 in total

1.  Fine particulate matter induces airway inflammation by disturbing the balance between Th1/Th2 and regulation of GATA3 and Runx3 expression in BALB/c mice.

Authors:  Lingling Pang; Pengfei Yu; Xueping Liu; Yingqi Fan; Ying Shi; Shenchun Zou
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

Review 2.  Runx Transcription Factors in T Cells-What Is Beyond Thymic Development?

Authors:  Svetlana Korinfskaya; Sreeja Parameswaran; Matthew T Weirauch; Artem Barski
Journal:  Front Immunol       Date:  2021-08-06       Impact factor: 7.561

3.  Methylation-dependent transcriptional repression of RUNX3 by KCNQ1OT1 regulates mouse cardiac microvascular endothelial cell viability and inflammatory response following myocardial infarction.

Authors:  Yanbin Wang; Xudong Yang; An Jiang; Wei Wang; Jian Li; Junmin Wen
Journal:  FASEB J       Date:  2019-10-18       Impact factor: 5.834

4.  Methylation Landscape of RUNX3 Promoter Region as a Predictive Marker for Th1/Th2 Imbalance in Bronchiolitis.

Authors:  Shuai Men; Yanyan Yu; Yuhong Zhang; Yifen Wang; Qian Qian; Wei Li; Chuang Yin
Journal:  Med Sci Monit       Date:  2019-10-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.